LESZEK MICHALEWICZ: Open Payments
NPI 1487718136 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 27 payments from 5 companies in 2025. Trend: 2023 $465 · 2024 $371 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $251 |
| E.R. Squibb & Sons, L.L.C. | 9 | $143 |
| Neurocrine BioSciences, Inc. | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 1 | $40 |
Products named: ARISTADA, COBENFY, INGREZZA, ABILIFY ASIMTUFII, UZEDY.
Industry payments across LA — which companies pay providers there.
